---
title: "AtriCure GAAP EPS of -$0.33 misses by $0.09, revenue of $124.28M beats by $2.44M"
date: "2025-02-13 00:03:03"
summary: "AtriCure press release (NASDAQ:ATRC): Q4 GAAP EPS of -$0.33 misses by $0.09. Revenue of $124.28M (+16.7% Y/Y) beats by $2.44M. 2025 Financial Guidance: Full year 2025 revenue is projected to be approximately $517 million to $527 million. Management now expects full year 2025 positive adjusted EBITDA of approximately $42 million..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* AtriCure [press release](https://seekingalpha.com/pr/20000550-atricure-reports-fourth-quarter-2024-and-full-year-2024-financial-results) (NASDAQ:[ATRC](https://seekingalpha.com/symbol/ATRC "AtriCure, Inc.")): Q4 GAAP EPS of -$0.33  misses by $0.09.
* Revenue of $124.28M (+16.7% Y/Y)  beats by $2.44M.
* **2025 Financial Guidance:** Full year 2025 revenue is projected to be approximately $517 million to $527 million. Management now expects full year 2025 positive adjusted EBITDA of approximately $42 million to $44 million. Full year 2025 adjusted loss per share is expected to be in the range of $0.57 to $0.64. Additionally, management expects modest cash flow generation for the full year 2025.

[seekalpha](https://seekingalpha.com/news/4407188-atricure-gaap-eps-of-0_33-misses-by-0_09-revenue-of-124_28m-beats-by-2_44m)
